02-634-0135 www.interpharma.co.th 4. MP Financial Statement Balance Sheet (Unit : Baht) 2017 Audited Statement 2018 Audited Statement 2019 Audited Statement Assets Current Assets Cash and cash

Baht 90,246.34 million, a decrease of Baht 4,682.03 million or 4.93% from the end of prior year. The drop mainly came from the reduction of cash which was used for loan repayment and the decrease of

and administrative expenses; 3) higher finance costs due to investments in machinery, and joint ventures in Thailand and overseas; 4) higher depreciation of investments in machinery and 5) non-cash, one

company loss on operating and negative equity. Then, the Company had tested impairment of investment in subsidiary by assessed the recoverable amount of cash generating units by Value-in-use method and

Period (Day) 58 58 66 CASH CYCLE (Day) 9 14 18 PROFITABILITY RATIO Gross Profit Margin (%) 8.57 7.82 10.37 Net Profit Margin (%) 4.61 3.56 5.94 Return on Equity (%) 6.03 5.01 8.05 EFFICIENCY RATIO Return

1.27% due to 1. Current assets increased amount of 455.90 million Baht or 309.71% consisting of Cash and cash equivalents decreased amount of 6.15 million Baht or 32.52%. Trade and other receivables

company loss on operating and negative equity .Then, the Company had tested impairment of investment in subsidiary by assessed the recoverable amount of cash generating units by Value-in-use method and

accounts receivable and other accounts receivable of Baht 50.44 million, increase in right of use assets of Baht 49.27 million, increase in cash and cash in bank of Baht 12.85 million, a net increase in

total asset (THB mn) % out of total asset Cash & cash equivalents and Current investments 484 29.7% 261 13.0% Trade & other receivables 276 16.9% 254 12.7% Building and equipment 176 10.8% 469 23.4

liabilities 69.46 101.98 -32.52 -31.9% Total liabilities 401.97 359.95 42.02 11.7% Total shareholders equity 580.51 578.57 1.94 0.3% Total liabilities plus shareholders equity 982.48 938.52 43.96 4.7% 3.3. Cash